These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16254698)

  • 1. Changes observed in multiple sclerosis using magnetic resonance imaging reflect a focal pathology distributed along axonal pathways.
    Arnold DL
    J Neurol; 2005 Nov; 252 Suppl 5():v25-9. PubMed ID: 16254698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.
    Filippi M; Rocca MA
    J Neurol; 2005 Nov; 252 Suppl 5():v16-24. PubMed ID: 16254697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology and disease mechanisms in different stages of multiple sclerosis.
    Lassmann H
    J Neurol Sci; 2013 Oct; 333(1-2):1-4. PubMed ID: 23735777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Sclerosis Pathology.
    Lassmann H
    Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 29358320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
    Brück W
    J Neurol; 2005 Nov; 252 Suppl 5():v3-9. PubMed ID: 16254699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain.
    Haider L; Zrzavy T; Hametner S; Höftberger R; Bagnato F; Grabner G; Trattnig S; Pfeifenbring S; Brück W; Lassmann H
    Brain; 2016 Mar; 139(Pt 3):807-15. PubMed ID: 26912645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
    Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
    Charil A; Filippi M
    J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuropathological basis of clinical progression in multiple sclerosis.
    Reynolds R; Roncaroli F; Nicholas R; Radotra B; Gveric D; Howell O
    Acta Neuropathol; 2011 Aug; 122(2):155-70. PubMed ID: 21626034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage.
    Owens T
    Curr Opin Neurol; 2003 Jun; 16(3):259-65. PubMed ID: 12858060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal injury in multiple sclerosis.
    Rammohan KW
    Curr Neurol Neurosci Rep; 2003 May; 3(3):231-7. PubMed ID: 12691628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences.
    Bjartmar C; Trapp BD
    Curr Opin Neurol; 2001 Jun; 14(3):271-8. PubMed ID: 11371748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegeneration and clinical relevance for early treatment in multiple sclerosis.
    Rieckmann P
    Int MS J; 2005 Aug; 12(2):42-51. PubMed ID: 16417814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study.
    Rocca MA; Preziosa P; Mesaros S; Pagani E; Dackovic J; Stosic-Opincal T; Drulovic J; Filippi M
    Radiology; 2016 Mar; 278(3):841-53. PubMed ID: 26348234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies.
    Imitola J; Chitnis T; Khoury SJ
    Arch Neurol; 2006 Jan; 63(1):25-33. PubMed ID: 16401734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue.
    Kalkers NF; Vrenken H; Uitdehaag BM; Polman CH; Barkhof F
    Mult Scler; 2002 Oct; 8(5):410-4. PubMed ID: 12356208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
    Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.